Polydex Pharmaceuticals Ltd. (POLXF) 股价，以美元计价

Polydex Pharmaceuticals Limited (the "Company") is engaged in the research, development, manufacture and marketing of biotechnology-based products for the veterinary and human pharmaceutical markets. This includes the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry. The Company focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The name Polydex combines the words "polymer" and "dextran." The Company conducts its business operations through its two wholly-owned subsidiaries/divisions. The manufacture and sale of Dextran and derivative products is conducted through Dextran Products, incorporated in Canada in 1966 (Dextran Products),and Chemdex Inc (Chemdex) which is incorporated in the state of Kansas, United States.FOR ADDITIONAL FINANCIAL INFORMATION AND NEWS, INCLUDING MORE RECENT QUARTERLY REPORTING, PLEASE VISIT OUR WEBSITE!